CN107592931A - 剂量计算器 - Google Patents
剂量计算器 Download PDFInfo
- Publication number
- CN107592931A CN107592931A CN201680027618.4A CN201680027618A CN107592931A CN 107592931 A CN107592931 A CN 107592931A CN 201680027618 A CN201680027618 A CN 201680027618A CN 107592931 A CN107592931 A CN 107592931A
- Authority
- CN
- China
- Prior art keywords
- user
- query
- insulin
- display
- carbohydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 54
- 238000000034 method Methods 0.000 claims abstract description 42
- 238000012545 processing Methods 0.000 claims abstract description 41
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 30
- 239000008103 glucose Substances 0.000 claims abstract description 30
- 230000004044 response Effects 0.000 claims abstract description 27
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 15
- 230000000977 initiatory effect Effects 0.000 claims abstract description 7
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 149
- 102000004877 Insulin Human genes 0.000 claims description 78
- 108090001061 Insulin Proteins 0.000 claims description 78
- 229940125396 insulin Drugs 0.000 claims description 75
- 238000012937 correction Methods 0.000 claims description 40
- 239000008280 blood Substances 0.000 claims description 19
- 210000004369 blood Anatomy 0.000 claims description 19
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 description 43
- 238000012360 testing method Methods 0.000 description 12
- 238000001514 detection method Methods 0.000 description 10
- 235000000346 sugar Nutrition 0.000 description 9
- 238000007726 management method Methods 0.000 description 8
- 238000004364 calculation method Methods 0.000 description 7
- 238000012986 modification Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 230000037396 body weight Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 229940123452 Rapid-acting insulin Drugs 0.000 description 3
- 108010026951 Short-Acting Insulin Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000012491 analyte Substances 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000835 electrochemical detection Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- CNQCVBJFEGMYDW-UHFFFAOYSA-N lawrencium atom Chemical compound [Lr] CNQCVBJFEGMYDW-UHFFFAOYSA-N 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
- A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562160892P | 2015-05-13 | 2015-05-13 | |
| US62/160,892 | 2015-05-13 | ||
| PCT/IB2016/052755 WO2016181351A1 (en) | 2015-05-13 | 2016-05-12 | Blood glucose management device for calculating bolus insulin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107592931A true CN107592931A (zh) | 2018-01-16 |
Family
ID=56081522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201680027618.4A Pending CN107592931A (zh) | 2015-05-13 | 2016-05-12 | 剂量计算器 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20180130551A1 (https=) |
| EP (1) | EP3295342B1 (https=) |
| JP (1) | JP2018517974A (https=) |
| CN (1) | CN107592931A (https=) |
| CA (1) | CA2984080A1 (https=) |
| WO (1) | WO2016181351A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3198598A1 (en) | 2017-05-05 | 2018-11-08 | Eli Lilly And Company | Closed loop control of physiological glucose |
| WO2019125932A1 (en) | 2017-12-21 | 2019-06-27 | Eli Lilly And Company | Closed loop control of physiological glucose |
| US11123137B2 (en) * | 2018-01-23 | 2021-09-21 | Modulight Oy | Method and system for operating biomedical laser |
| CN112313754A (zh) | 2018-06-22 | 2021-02-02 | 伊莱利利公司 | 胰岛素和普兰林肽输送系统、方法和设备 |
| FR3100973B1 (fr) | 2019-09-25 | 2023-05-05 | Air Liquide | Dispositif pour déterminer et afficher une dose d’insuline à administrer à un patient diabétique |
| EP4088285A4 (en) * | 2020-01-08 | 2024-01-24 | Dexcom, Inc. | BOLUS DOSE MANAGEMENT |
| EP4039293A1 (en) * | 2021-02-05 | 2022-08-10 | Insulet Corporation | Techniques and devices for adaptation of maximum drug delivery limits |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101801262A (zh) * | 2007-07-09 | 2010-08-11 | 弗吉尼亚大学专利基金会 | 糖尿病胰岛素敏感度、碳水化合物比、校正因子数据自我监测产品 |
| US20120245447A1 (en) * | 2011-02-28 | 2012-09-27 | Abbott Diabetes Care Inc. | Devices, Systems, and Methods Associated with Analyte Monitoring Devices and Devices Incorporating the Same |
| US20140379360A1 (en) * | 2013-06-25 | 2014-12-25 | Lifescan, Inc. | Low glucose treatment for people with diabetes |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070078314A1 (en) * | 2005-09-30 | 2007-04-05 | Grounsell Richard L | System and method for measuring and predicting insulin dosing rates |
| US20080228056A1 (en) * | 2007-03-13 | 2008-09-18 | Michael Blomquist | Basal rate testing using frequent blood glucose input |
| WO2009075925A1 (en) * | 2007-12-13 | 2009-06-18 | Shaya Steven A | Method and apparatus to calculate diabetic sensitivity factors affecting blood glucose |
| PT2260423T (pt) * | 2008-04-04 | 2018-05-30 | Hygieia Inc | Aparelho para optimizar o regime de dosagem de insulina a um paciente |
| US20140121634A1 (en) * | 2012-07-11 | 2014-05-01 | Caren Frances Thomson | Method, system and apparatus for setting insulin dosages for diabetics |
-
2016
- 2016-05-12 EP EP16725237.8A patent/EP3295342B1/en active Active
- 2016-05-12 JP JP2017558972A patent/JP2018517974A/ja active Pending
- 2016-05-12 US US15/569,302 patent/US20180130551A1/en not_active Abandoned
- 2016-05-12 CN CN201680027618.4A patent/CN107592931A/zh active Pending
- 2016-05-12 CA CA2984080A patent/CA2984080A1/en not_active Abandoned
- 2016-05-12 WO PCT/IB2016/052755 patent/WO2016181351A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101801262A (zh) * | 2007-07-09 | 2010-08-11 | 弗吉尼亚大学专利基金会 | 糖尿病胰岛素敏感度、碳水化合物比、校正因子数据自我监测产品 |
| US20120245447A1 (en) * | 2011-02-28 | 2012-09-27 | Abbott Diabetes Care Inc. | Devices, Systems, and Methods Associated with Analyte Monitoring Devices and Devices Incorporating the Same |
| US20140379360A1 (en) * | 2013-06-25 | 2014-12-25 | Lifescan, Inc. | Low glucose treatment for people with diabetes |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3295342B1 (en) | 2021-08-25 |
| US20180130551A1 (en) | 2018-05-10 |
| JP2018517974A (ja) | 2018-07-05 |
| CA2984080A1 (en) | 2016-11-17 |
| EP3295342A1 (en) | 2018-03-21 |
| WO2016181351A1 (en) | 2016-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107592931A (zh) | 剂量计算器 | |
| CN102802522B (zh) | 具有胰岛素给药安全警告的分析物测试方法和系统 | |
| JP6461885B2 (ja) | 糖尿病管理のための分析物試験方法及びデバイス | |
| AU2011207314B2 (en) | Analyte testing method and system | |
| US8615366B2 (en) | Handheld diabetes management device with bolus calculator | |
| JP5329562B2 (ja) | 試験システム | |
| CN103025242B (zh) | 确保关于平均餐前和餐后葡萄糖差值消息传递的统计功效的方法、系统和装置 | |
| US9213802B2 (en) | Updatability of structured blood glucose tests performed on handheld diabetes management devices | |
| CN104470430A (zh) | 指示糖尿病人群高血糖或低血糖的方法和系统 | |
| CN104620246A (zh) | 指示胰岛素注入泵命令的血糖影响的方法和系统 | |
| HK1245938A1 (en) | Blood glucose management device for calculating bolus insulin | |
| AU2011273189B8 (en) | Methods to ensure statistical power for average pre and post - prandial glucose difference messaging | |
| HK1188311B (en) | Updatability of structured blood glucose tests on handheld diabetes management devices | |
| HK1188311A (en) | Updatability of structured blood glucose tests on handheld diabetes management devices | |
| AU2015202434A1 (en) | Analyte testing method and system | |
| HK1194649B (en) | Analyte testing method and device for diabetes management | |
| HK1242157A1 (en) | Smart logging for management of health-related issues | |
| HK1189787B (en) | Analyte testing method and device for diabetes management | |
| HK1194649A (en) | Analyte testing method and device for diabetes management | |
| HK1189787A (en) | Analyte testing method and device for diabetes management | |
| HK1172225B (en) | Analyte testing method and device for diabetes management |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1245938 Country of ref document: HK |
|
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180116 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1245938 Country of ref document: HK |